NCT06247813 - Pilot Study: Impact of Biomarker-Guided Dietary Supplementation on Quality-of-Life Measures in Subjects With Chronic Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 8, 2024

Primary Completion Date

February 15, 2025

Study Completion Date

July 30, 2025

Conditions

Chronic Pain

Interventions

DIETARY_SUPPLEMENT

Inflammation Support Formula

Turmeric Extract (400mg), Bioperine (Black pepper, 10mg), Ashwagandha (500mg), and Olive Leaf Extract (250mg).

DIETARY_SUPPLEMENT

Nerve Health Formula

Hydroxocobalamin (Vitamin B12, 1000mcg), Pyridoxal-5-Phosphate (Vitamin B6, 50mg), LMethylfolate (400mcg) and Trimethyl Glycine (Betaine, 750mg).

DIETARY_SUPPLEMENT

Redox Support Formula

N-Acetyl-L-Cysteine (500mg), CoQ10 (250mg), Acetyl-L-Carnitine (200mg), Alpha Lipoic Acid (200mg), Benfotiamine (300mg), Selenium (250mcg), Riboflavin (50mg), Zinc (15mg) and Copper (1.8mg).

Trial Locations (1)

41071

RECRUITING

Ethos Research and Development, Newport